Crinetics Pharmaceuticals, Inc. (CRNX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$37.75
Day's range
$39.25

Crinetics Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/17/2026 14.29 M $665.38 M   0.75% 15.17%
VANGUARD GROUP INC 01/29/2026 9.14 M $425.26 M   -0.38% 9.70%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 8.04 M $374.16 M   -4.11% 8.53%
BLACKROCK, INC. 02/12/2026 7.99 M $371.87 M   5.30% 8.48%
FARALLON CAPITAL MANAGEMENT LLC 02/17/2026 6.93 M $322.74 M   20.16% 7.36%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/17/2026 6.39 M $297.35 M   -1.45% 6.78%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 5.22 M $243.20 M   -1.54% 5.55%
JANUS HENDERSON GROUP PLC 02/17/2026 4.44 M $206.60 M   15.08% 4.71%
ECOR1 CAPITAL, LLC 02/17/2026 4.29 M $199.61 M   0.00% 4.55%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 2.34 M $108.79 M   16.66% 2.48%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 2.24 M $104.41 M   -1.59% 2.38%
PARADIGM BIOCAPITAL ADVISORS LP 02/17/2026 2.21 M $102.91 M   -13.33% 2.35%
STATE STREET CORP 02/13/2026 2.16 M $100.61 M   -2.10% 2.29%
BAKER BROS. ADVISORS LP 02/17/2026 1.65 M $76.75 M   488.88% 1.75%
NOVO HOLDINGS A/S 02/17/2026 1.63 M $75.64 M   0.00% 1.72%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 1.56 M $72.63 M   6.49% 1.66%
SIREN, L.L.C. 02/13/2026 1.51 M $70.18 M   -10.72% 1.60%
GW&K INVESTMENT MANAGEMENT, LLC 02/11/2026 1.48 M $68.72 M   73.57% 1.57%
RTW INVESTMENTS, LP 02/17/2026 1.35 M $62.90 M   54.90% 1.43%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 02/13/2026 1.33 M $61.79 M   59.15% 1.41%
JENNISON ASSOCIATES LLC 01/30/2026 1.28 M $59.66 M   -37.32% 1.36%
FIRST LIGHT ASSET MANAGEMENT, LLC 02/17/2026 1.19 M $55.59 M   26.84% 1.27%
JPMORGAN CHASE & CO 02/11/2026 1.15 M $53.75 M   -8.26% 1.23%
AMERICAN CENTURY COMPANIES INC 02/13/2026 1.07 M $49.76 M   -5.70% 1.13%
ORBIMED ADVISORS LLC 02/17/2026 999.00 K $46.50 M   -9.10% 1.06%
UBS GROUP AG 01/29/2026 908.19 K $42.28 M   122.75% 0.96%
HOOD RIVER CAPITAL MANAGEMENT LLC 02/17/2026 897.40 K $41.77 M   1.63% 0.95%
CANDRIAM S.C.A. 04/30/2026 830.96 K $38.68 M   11.52% 0.88%
BANK OF AMERICA CORP /DE/ 02/17/2026 801.31 K $37.30 M   33.32% 0.85%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 781.98 K $36.40 M   0.43% 0.83%
NORTHERN TRUST CORP 02/17/2026 769.82 K $35.84 M   -4.95% 0.82%
MORGAN STANLEY 02/13/2026 768.83 K $35.79 M   12.71% 0.82%
FISHER ASSET MANAGEMENT, LLC 02/09/2026 758.66 K $35.32 M   0.04% 0.81%
ABRDN PLC 01/16/2026 674.53 K $31.40 M   98.42% 0.72%
AMERIPRISE FINANCIAL INC 02/17/2026 601.19 K $27.99 M   -2.22% 0.64%
FIERA CAPITAL CORP 02/11/2026 578.46 K $26.93 M   32.85% 0.61%
GOLDMAN SACHS GROUP INC 03/25/2026 567.13 K $26.40 M   -20.47% 0.60%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 548.98 K $25.56 M   45.31% 0.58%
NUVEEN, LLC 02/12/2026 522.47 K $24.32 M   -4.09% 0.55%
UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 01/28/2026 408.31 K $19.01 M   5.26% 0.43%
BANK OF NEW YORK MELLON CORP 02/10/2026 405.01 K $18.85 M   1.35% 0.43%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 398.40 K $18.55 M   63.35% 0.42%
IKARIAN CAPITAL, LLC 02/18/2026 368.50 K $17.15 M   100.00% 0.39%
ADAR1 CAPITAL MANAGEMENT, LLC 02/18/2026 309.37 K $14.40 M   24.56% 0.33%
VOYA INVESTMENT MANAGEMENT LLC 02/12/2026 302.00 K $14.06 M   770.47% 0.32%
MILLENNIUM MANAGEMENT LLC 02/17/2026 300.34 K $13.98 M   38.89% 0.32%
CORMORANT ASSET MANAGEMENT, LP 02/17/2026 300.00 K $13.97 M   -25.00% 0.32%
ENSIGN PEAK ADVISORS, INC 02/12/2026 275.62 K $12.83 M   -6.57% 0.29%
IMPAX ASSET MANAGEMENT GROUP PLC 01/29/2026 275.00 K $12.80 M   100.00% 0.29%
PROSIGHT MANAGEMENT, LP 02/13/2026 262.90 K $12.24 M   -20.01% 0.28%

Crinetics Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 315 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals Inc. The most heavily invested institutionals were:

Pictet Asset Management Holding SA: 1.88 M

JENNISON ASSOCIATES LLC: 904,672

DIMENSIONAL FUND ADVISORS LP: 852,258

Candriam S.C.A.: 830,961

abrdn plc: 820,395

Fisher Asset Management, LLC: 762,702

118.46% of Crinetics Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 121.41 M shares in the last 24 months. This purchase volume represents approximately $4.64 B in transactions.